Hydroxyurea, a new drug, does not seem to be effective in reducing the risk of recurrent stroke in children with sickle cell anemia and iron overload.
The National Heart, Lung, and Blood Institute (NHLBI), US, said it was giving up a major trial as there was no evidence that the drug could be any better than the existing treatment.
New Drug Not Effective In Preventing Stroke In Anemic Children
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment